Peter Donnelly Selected Research

Peter Donnelly Research Topics

Disease

7	Neoplasms (Cancer) 03/2024 - 03/2012
5	Breast Neoplasms (Breast Cancer) 08/2023 - 02/2012
4	Infections 10/2015 - 07/2004
3	Mycoses (Diseases, Fungus) 05/2020 - 09/2015
2	Viral Bronchiolitis 12/2023 - 01/2021
2	COVID-19 11/2023 - 01/2022
2	Communicable Diseases (Infectious Diseases) 05/2020 - 06/2016
2	Aspergillosis 10/2015 - 09/2015
2	Disease Susceptibility (Diathesis) 10/2013 - 07/2011
2	Ankylosing Spondylitis 07/2013 - 07/2011
1	Triple Negative Breast Neoplasms 03/2024
1	Bronchiolitis 12/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2023
1	Coinfection 01/2021
1	Invasive Pulmonary Aspergillosis 05/2020
1	Infertility (Sterility) 01/2020
1	Acne Vulgaris 10/2018
1	Asthma (Bronchial Asthma) 10/2018
1	Gallstones (Gallstone) 10/2018
1	Gout 10/2018
1	Intellectual Disability (Idiocy) 10/2017
1	Bacteremia 06/2016
1	Multiple Sclerosis 10/2015
1	Marijuana Use 03/2014
1	Hypothyroidism 11/2013
1	Congenital Dyserythropoietic Anemia (Dyserythropoietic Anemia, Congenital) 09/2013
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 03/2013
1	Congenital Disorders of Glycosylation 03/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Hiatal Hernia 10/2012
1	Barrett Esophagus (Barrett's Esophagus) 10/2012
1	Adenocarcinoma 10/2012
1	Sepsis (Septicemia) 03/2012
1	Stroke (Strokes) 02/2012
1	Ataxia (Dyssynergia) 01/2012
1	Cerebellar Ataxia (Dysmetria) 01/2012
1	Infantile Spasms (West Syndrome) 01/2012
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2012
1	Autosomal Recessive Cerebellar Ataxia Type 1 01/2012
1	Cognitive Dysfunction 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 02/2011
1	Type 2 Diabetes Mellitus (MODY) 02/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2010
1	Stomatitis 01/2009
1	Pneumonia (Pneumonitis) 07/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2004
1	Neutropenia 07/2004

Drug/Important Bio-Agent (IBA)

3	beta-Aminoethyl Isothiourea (AET)IBA 08/2023 - 07/2017
3	Proteins (Proteins, Gene)FDA Link 10/2013 - 02/2012
2	Sodium Glutamate (Accent)IBA 10/2015 - 09/2015
2	Peptides (Polypeptides)IBA 07/2013 - 07/2011
2	AminopeptidasesIBA 07/2013 - 07/2011
1	Phenobarbital (Luminal)FDA Link 03/2024
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2020
1	CholesterolIBA 10/2018
1	AMPA Receptors (AMPA Receptor)IBA 10/2017
1	2-aminoethanethiosulfonic acidIBA 07/2017
1	Untranslated RNA (Noncoding RNA)IBA 06/2016
1	Long Noncoding RNAIBA 06/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2015
1	Illicit Drugs (Recreational Drugs)IBA 03/2014
1	inhibin BIBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	EndonucleasesIBA 09/2013
1	HLA-B Antigens (HLA-B)IBA 07/2013
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2013
1	AsparagineIBA 03/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	P-2 (P 2)IBA 01/2013
1	AcidsIBA 10/2012
1	Methicillin (Metin)FDA Link 03/2012
1	Anti-Infective Agents (Microbicides)IBA 03/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2012
1	SpectrinIBA 01/2012
1	Codon (Codons)IBA 01/2012
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2011
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 02/2011
1	Metformin (Glucophage)FDA LinkGeneric 02/2011
1	AMP-Activated Protein KinasesIBA 02/2011
1	HLA-C Antigens (HLA-C)IBA 11/2010

Therapy/Procedure

6	Therapeutics 08/2023 - 02/2011
4	Drug Therapy (Chemotherapy) 10/2015 - 01/2009
3	Critical Care (Surgical Intensive Care) 12/2023 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 12/2023 - 01/2021
2	Aftercare (After-Treatment) 01/2018 - 07/2017
1	Mastectomy (Mammectomy) 03/2024
1	Segmental Mastectomy (Lumpectomy) 03/2024
1	Personal Protective Equipment 11/2023
1	Duration of Therapy 05/2020
1	Stem Cell Transplantation 05/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2020
1	Radiotherapy 01/2009
1	Induction Chemotherapy 07/2004